These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 9606663)

  • 1. [Comparative cytochemical study of the central nervous system in Wistar and August rats in dopamine system hyperfunction].
    Sergutina AV
    Morfologiia; 1998; 113(1):51-3. PubMed ID: 9606663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurochemical characteristics of the effects of delta sleep-inducing peptide in Wistar rats with hyperactivity of the dopaminergic system.
    Sergutina AV; Gershtein LM
    Bull Exp Biol Med; 2000 Nov; 130(11):1074-6. PubMed ID: 11182819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of withdrawal from L-DOPA compounds on pathochemical changes of motor structures of the brain caused by them].
    Gershteĭn LM; Sergutina AV; Kukuev LA
    Vopr Med Khim; 1994; 40(5):4-8. PubMed ID: 7839669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Morphochemical analysis of hippocampus of rats predisposed (August) or resistant (Wistar) to emotional stress].
    Sergutina AV; Gershteĭn LM
    Morfologiia; 2004; 125(2):15-8. PubMed ID: 15232864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in the enzyme activity in the brain structures of August rats under the influence of the delta sleep-inducing peptide against a background of prolonged L-dihydroxyphenylalanine administration].
    Sergutina AV; Rakhmanova VI
    Morfologiia; 1999; 116(6):9-11. PubMed ID: 10709190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurochemical aspects of the cortical-subcortical interrelations after activation of the dopamine system with L-dopa].
    Gershteĭn LM; Sergutina AV; Titov SA; Chebotareva TL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(10):68-71. PubMed ID: 1963003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of L-DOPA on rat brain depending on individual behavioral features].
    Sergutina AV; Gershteĭn LM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(12):56-9. PubMed ID: 15849866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in Monoamine Oxidase Activity in the Brain of Wistar and August Rats with High and Low Locomotor Activity: A Cytochemical Study.
    Sergutina AV; Rakhmanova VI
    Bull Exp Biol Med; 2016 Jun; 161(2):211-4. PubMed ID: 27383157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A cytochemical study of the effect of tuftsin on the enzyme activity in functionally different formations of the brain in rats].
    Sergutina AV
    Tsitologiia; 1991; 33(12):67-72. PubMed ID: 1841460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Origin of various enzymes released from the substantia nigra and caudate nucleus: effects of 6-hydroxydopamine lesions of the nigro-striatal pathway.
    Greenfield SA; Grünewald RA; Foley P; Shaw SG
    J Comp Neurol; 1983 Feb; 214(1):87-92. PubMed ID: 6404955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytochemical research on the effect of a synthetic enkephalin analog on the protein content and enzyme activity of neurons].
    Gershteĭn LM; Sergutina AV; Khudoerkov RM
    Tsitologiia; 1985 Sep; 27(9):1059-63. PubMed ID: 4060231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of D3 receptors in the zitter mutant rat is not reversed by L-dopa treatment.
    Joyce JN; Der TC; Renish L; Osredkar T; Hagner D; Reploge M; Sakakibara S; Ueda S
    Exp Neurol; 2004 May; 187(1):178-89. PubMed ID: 15081599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Morpho-chemical characteristics of the brain of rats genetically predisposed to catalepsy].
    Il'enkova MA; Sergutina AV; Gershteĭn LM; Popova NK
    Arkh Anat Gistol Embriol; 1990 Jul; 99(7):44-8. PubMed ID: 2252435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biogenic amines in the brain nuclei of August and Wistar rats under repeated stress].
    Gorbunova AV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1998; 48(6):1051-7. PubMed ID: 9929914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The morphochemical characteristics of the reaction of the motor structures of the brain to hyper- and hypofunction of the dopaminergic system].
    Gershteĭn LM; Dovedova EL; Dobrynina MT; Sergutina AV; Rakhmanova VI
    Zh Nevrol Psikhiatr Im S S Korsakova; 1996; 96(6):49-53. PubMed ID: 9072895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain acetylcholinesterase activity in Wistar and August rats with low and high motor activity (a cytochemical study).
    Sergutina AV; Rakhmanova VI
    Bull Exp Biol Med; 2014 Aug; 157(4):450-3. PubMed ID: 25110081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of neuromediators and proteins in genetic and functional organization of animal brain].
    Gershteĭn LM
    Ontogenez; 2001; 32(1):35-40. PubMed ID: 11234391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of 3-methoxytyramine in rat brain by HPLC with electrochemical detection and its correlation with dopamine function after administration of a monoamine oxidase inhibitor and L-3,4-dihydroxyphenylalanine.
    Davies CL; Heal DJ
    J Neurochem; 1986 Dec; 47(6):1919-23. PubMed ID: 3772383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of the action of the delta sleep-inducing peptide against a background of L-DOPA administration].
    Dovedova EL
    Biull Eksp Biol Med; 1989 Apr; 107(4):440-2. PubMed ID: 2720161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAO activity in rat brain stem and cerebral cortex following acute and chronic treatment with L-dopa and ethanol + L-dopa.
    Renis M; Giovine A; Bertolino A
    Pharmacology; 1977; 15(5):392-9. PubMed ID: 918143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.